GlassScriptPhysician profile
Preeti Divekar
NPI 1356544589
$3,079.65
in general payments reported to CMS, 2019-2025
23 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,025 · 2020: $230 · 2021: $130 · 2022: $446 · 2023: $702 · 2024: $161 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,248.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $534.21 | 2022-2023 | Evenity, Prolia |
| Abbvie INC. | $441.58 | 2019-2022 | |
| Coopersurgical, INC. | $430.77 | 2019-2025 | Endosee, Paragard T 380a, Mara Console |
| Minerva Surgical, INC | $202.69 | 2019 | |
| Organon LLC | $199.23 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $186.34 | 2021-2025 | |
| Hologic Sales and Service, LLC | $124.26 | 2019-2024 | Aptima, Thinprep 2000 Processor, Omni Hysteroscope |
| Astellas Pharma US INC | $122.88 | 2019 | |
| Radius Health, INC. | $122.27 | 2019 | |
| Novo Nordisk INC | $118.72 | 2023-2025 | Wegovy |
| Exeltis, USA INC. | $94.47 | 2020-2025 | Slynd |
| Millicent US INC | $83.49 | 2025 | Intrarosa, Femlyv |
| Amag Pharmaceuticals, INC. | $79.36 | 2019 | |
| Pfizer INC. | $61.60 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $53.11 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $39.33 | 2019 | |
| Caldera Medical, INC | $38.73 | 2025 | |
| Allergan, INC. | $38.10 | 2019-2021 | |
| Virtus Pharmaceuticals LLC | $33.15 | 2021-2022 | |
| Agile Therapeutics, INC. | $23.95 | 2021 | |
| Merz North America, INC. | $20.45 | 2019 | |
| Myovant Sciences INC. | $18.76 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Divekar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.